SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001214659-22-002032
Filing Date
2022-02-08
Accepted
2022-02-08 13:04:56
Documents
7

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 5 e126221sc13da5.htm SC 13D/A 68193
2 GRAPHIC image_001.jpg GRAPHIC 370384
3 GRAPHIC image_002.jpg GRAPHIC 479867
4 GRAPHIC image_003.jpg GRAPHIC 497035
5 GRAPHIC image_004.jpg GRAPHIC 239045
6 GRAPHIC image_005.jpg GRAPHIC 215035
7 GRAPHIC image_006.jpg GRAPHIC 135424
  Complete submission text file 0001214659-22-002032.txt   2737702
Mailing Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 813-766-9539
EYENOVIA, INC. (Subject) CIK: 0001682639 (see all company filings)

IRS No.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90395 | Film No.: 22600323
SIC: 2834 Pharmaceutical Preparations

Mailing Address 11 SUMMIT LANE GREENVILLE DE 19807
Business Address
Grant Stuart M. (Filed by) CIK: 0001783415 (see all company filings)

Type: SC 13D/A